Integrated Nanotherapeutics Inc. is a biopharmaceutical company dedicated to the development of novel drugs in the areas of cancer and autoimmunity, including diabetes, where there is significant unmet medical need for therapeutic agents with improved activity. Our proprietary technologies allow the incorporation of any compound in lipid nanoparticle delivery systems and thus extend the benefits of delivery systems to virtually any therapeutic and diagnostic agent. We envision that many existing drugs or agents can be made much safer and more effective using our technologies.